OBO_ID (LABEL):	GO_0043651 (linoleic acid metabolic process)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC2658734	4/2009	S62-PMC2658734	['caption (table-wrap): table\xa01\n\nvalidated and hypothetic Mirna targetsvalidated Mirna targets in type 2 diabetes and in the Endocrine systemmirnatargetfunctionreferencemir-375myotrophininhibition of Insulin secretion[69]mir-9onecut2 transcription factorinhibition of Glucose-stimulated Insulin Release[70]mir-192e-box repressorstgf-Beta-Induced Matrix Protein Collagen Col1A1 and -2[24]mir-143glut4, Hsl, Fatty Acid-Binding protein Ap2, Ppar-Μ2Adipocyte differentiation[49]hypothetic Mirna targets associated with type 2 diabetesmir-30 familyreceptor for advanced glycation end product, Immediate Early Response 3, Vimentin, Heat-Shock Protein-20Podocyte Apoptosis and Cytoskeletal structure[79,80]Mir-23Bhairy/Enhancer Of The Split Protein (Hes1)downstream target of activated Notch Signalling and Expressed in Nephron segments during development[81,84]mir-15, mir-16wnt and Β-Cateninnephron induction during Embryo Development[75,76]mir-7gy-boxnotch signalling[73,74]mir-4, mir-79Brd-boxmir-2, mir-11k-box\nBiogenesis Of Mirnas starts in the Nucleus (see figure3) where stretches of several kilobases long primary Mirnas (pri-Mirnas) are transcribed from the Genome, 3′- Polyadenylated [covalent Linkage Poly (a) tail of 3′ end of Mirna], 5′- capped [7-methyl guanylate (m7g) cap of 5′ end of Mirna].']	N/A	N/A	[('SO_0000276', 'miRNA', 56, 'miRNA'), ('SO_0000276', 'miRNA', 79, 'miRNA'), ('UBERON_0002049', 'vasculature', 123, 'endocrine'), ('PR_000045358', 'insulin family protein', 198, 'insulin'), ('CHEBI_17234', 'glucose', 266, 'glucose'), ('PR_000045358', 'insulin family protein', 285, 'insulin'), ('GO_0006260', 'DNA replication', 293, 'release'), ('PR_000004670', 'protein PTHB1', 330, '-beta-induced matrix protein collagen'), ('GO_0031012', 'extracellular matrix', 344, 'matrix'), ('PR_000003266', 'collagen type II alpha chain', 368, 'Col1a1'), ('PR_000010222', 'muscleblind-like protein 2', 380, '2'), ('PR_000008794', 'heat shock factor protein 5', 399, 'HSL'), ('CHEBI_35366', 'fatty acid', 404, 'fatty acid'), ('PR_000010000', 'lysozyme g-like protein 2', 414, '-binding'), ('PR_000004123', 'adenomatous polyposis coli protein 2', 431, 'aP2'), ('PR_000013031', 'periostin', 436, 'PPAR-μ2Adipocyte'), ('SO_0000276', 'miRNA', 483, 'miRNA'), ('PR_000000035', 'BMP receptor type-1A', 531, '-30'), ('PR_000008890', 'isocitrate dehydrogenase [NAD] subunit beta, mitochondrial', 586, 'immediate early response 3'), ('PR_000017283', 'vitamin D3 receptor', 614, 'vimentin'), ('PR_000005163', 'CD2-associated protein', 624, 'heat-shock protein-20Podocyte'), ('GO_0006915', 'apoptotic process', 654, 'apoptosis'), ('GO_0005856', 'cytoskeleton', 668, 'cytoskeletal'), ('PR_000002103', 'sodium channel protein type 8 subunit alpha', 697, 'miR-23bHairy'), ('PR_000006890', 'enhancer of mRNA-decapping protein 3', 710, 'enhancer of the split protein'), ('SO_0000165', 'enhancer', 710, 'enhancer'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 741, 'Hes1'), ('GO_0038189', 'neuropilin signaling pathway', 777, 'Notch signalling'), ('GO_0010467', 'gene expression', 798, 'expressed'), ('UBERON_0001285', 'nephron', 811, 'nephron'), ('PR_000002198', 'catenin beta-1', 875, 'β-cateninNephron'), ('GO_0009790', 'embryo development', 909, 'embryo development'), ('UBERON_0000922', 'embryo', 909, 'embryo'), ('PR_000011040', 'nuclear receptor coactivator 1', 979, '79Brd'), ('PR_000010222', 'muscleblind-like protein 2', 992, '2'), ('GO_0070277', 'iodide oxidation', 1007, 'Biogenesis of miRNAs'), ('SO_0000276', 'miRNA', 1021, 'miRNAs'), ('GO_0005634', 'nucleus', 1042, 'nucleus'), ('SO_0000276', 'miRNA', 1114, 'miRNAs'), ('SO_0000276', 'miRNA', 1126, 'miRNAs'), ('SO_0001026', 'genome', 1159, 'genome'), ('GO_0043651', 'linoleic acid metabolic process', 1171, 'polyadenylated'), ('SO_0000987', 'linear', 1196, 'linkage'), ('SO_0000610', 'polyA_sequence', 1204, 'poly'), ('SO_0000276', 'miRNA', 1231, 'miRNA'), ('SO_0000276', 'miRNA', 1293, 'miRNA')]
PMC4213680	12/2014	S75-PMC4213680	['total rna was treated with dnase i (rnase free, d2215, takara, japan), and six micrograms of treated total rna were Polyadenylated by poly (a) polymerase at 37°c for 1 h in a 25 μl reaction Mixture using poly (a) tailing kit (am1350, ambion, grand island, new york, usa) according to the manufacturer’s instructions.']	N/A	N/A	[('GO_0043651', 'linoleic acid metabolic process', 116, 'polyadenylated'), ('CHEBI_60004', 'mixture', 190, 'mixture')]
PMC4213680	12/2014	S76-PMC4213680	['two micrograms of Polyadenylated rna were Reverse Transcribed using Poly (T) Adapter.']	N/A	N/A	[('GO_0043651', 'linoleic acid metabolic process', 18, 'polyadenylated'), ('GO_0001171', 'reverse transcription', 42, 'reverse transcribed'), ('SO_0000043', 'processed_pseudogene', 68, 'poly (T) adapter')]
PMC4683322	11/2015	S3-PMC4683322	['rna was Polyadenylated by Poly (A) Polymerase and then dissolved and Reverse Transcribed using Poly (T) Adapter.']	N/A	N/A	[('GO_0043651', 'linoleic acid metabolic process', 8, 'polyadenylated'), ('SO_0000610', 'polyA_sequence', 26, 'poly (A) polymerase'), ('GO_0001171', 'reverse transcription', 69, 'reverse transcribed'), ('SO_0000043', 'processed_pseudogene', 95, 'poly (T) adapter')]
PMC4937150	2/2016	S58-PMC4937150	['two μ g of total rna from each piglet were Polyadenylated by poly(A) polymerase (pap) at 37°c for 1 hr using a poly(a) tailing kit (am1350; ambion, rockford, il, u.s.a.), according to the manufacturer’s instructions.']	N/A	N/A	[('GO_0043651', 'linoleic acid metabolic process', 43, 'polyadenylated'), ('SO_0001434', 'cassette_pseudogene', 65, '(A)')]
